Skip to main content
. 2018 May 10;84(3):717–725. doi: 10.1093/neuros/nyy178

FIGURE 1.

FIGURE 1.

Selection process for the study cohort. A total of 398 patients were treated with SRS at 10 participating institutions of the IGKRF. After excluding 20 patients for a lack of documented endocrine outcome after SRS and 7 patients for endocrine follow-up <6 mo, the study cohort was comprised of 371 SRS-treated acromegaly patients with ≥6 mo endocrine follow-up.